Cancer immunotherapy became a potential target to treat cancer in the last decade and iNKT cells showed unique features and multiple mechanisms to target cancer cells, i.e., direct killing of CD1d+ tumors, and adjuvant effects by recruiting NK cells and dendritic cells, further activating cytotoxic T lymphocytes and inhibition of tumor-associated macrophages [9]. Here, CD1D is linked to cancer.